홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

6-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-2-methylnicotinamide → HCID 178433153, 화합물

HRID 923145
인쇄

반응식

HRID 923145 반응식
Cl[C:2]1[CH:23]=[CH:22][C:5]([C:6]([NH:8][C:9]2[CH:14]=[CH:13][C:12]([Cl:15])=[C:11]([C:16]3[CH:21]=[CH:20][CH:19]=[CH:18][N:17]=3)[CH:10]=2)=[O:7])=[C:4]([CH3:24])[N:3]=1.[NH2:25][CH2:26][CH2:27][C:28]1[N:32]=[CH:31][NH:30][CH:29]=1>C(O)CCC>[NH:30]1[CH:29]=[C:28]([CH2:27][CH2:26][NH:25][C:2]2[CH:23]=[CH:22][C:5]([C:6]([NH:8][C:9]3[CH:14]=[CH:13][C:12]([Cl:15])=[C:11]([C:16]4[CH:21]=[CH:20][CH:19]=[CH:18][N:17]=4)[CH:10]=3)=[O:7])=[C:4]([CH3:24])[N:3]=2)[N:32]=[CH:31]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 586147986-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-2-methylnicotinamideHCID 178419017HCID 178419017, 화합물

생성물 1

HCID 178433153HCID 178433153, 화합물

시약·촉매·용매 1

HCID 2631-Butanol용매

실험 절차

Procedure F was performed using 60 mg of 6-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-2-methylnicotinamide and 93 mg of histamine in 0.5 mL of BuOH. Purified by reverse phase HPLC to yield 6-(2-(1H-imidazol-4-yl)ethylamino)-N-(4-chloro-3-(pyridin-2-yl)phenyl)-2-methylnicotinamide. MS (Q1) 433.0 (M)

후처리

  1. customPurified by reverse phase HPLC

출처 및 근거

ORD 기록
ord-00f3bd887d6145b69e6bd0b478c50d44
출처 데이터셋
uspto-grants-2016_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09278961B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트